Page last updated: 2024-08-22

indocyanine green and Prostatic Neoplasms, Castration-Resistant

indocyanine green has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cao, W; Cui, D; Hou, N; Li, W; Liu, B; Liu, Y; Tan, H; Wang, Z; Xu, B; Zheng, D1

Other Studies

1 other study(ies) available for indocyanine green and Prostatic Neoplasms, Castration-Resistant

ArticleYear
CD133 antibody targeted delivery of gold nanostars loading IR820 and docetaxel for multimodal imaging and near-infrared photodynamic/photothermal/chemotherapy against castration resistant prostate cancer.
    Nanomedicine : nanotechnology, biology, and medicine, 2020, Volume: 27

    Topics: AC133 Antigen; Animals; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; Docetaxel; Drug Delivery Systems; Gold; Heterografts; Humans; Indocyanine Green; Male; Mice; Molecular Targeted Therapy; Multimodal Imaging; Nanoparticles; Photochemotherapy; Photothermal Therapy; Prostatic Neoplasms, Castration-Resistant

2020